No Elevated Cancer Risk for RA Patients With Tocilizumab (CME/CE)
(MedPage Today) -- Combined risk for new cancers except non-melanoma skin cancer with IL-6r inhibitor not significantly different than with TNF inhibitors
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Actemra | Cancer | Cancer & Oncology | Hematology | Melanoma | Nonmelanoma Skin Cancer | Skin | Skin Cancer